SCHEMBL24567209

SCHEMBL24567209

CC(C)(C)C(=O)Nc1cc(Cl)nn([C@@H]2CCOC2)c1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ MITF O75030 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ KLF5 Q13887 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ IRAK4 Q9NWZ3 3/20 0.35
▸ PDE1A P54750 1/20 0.35
▸ PDE1B Q01064 1/20 0.35
▸ PDE1C Q14123 1/20 0.35
▸ SPR P35270 1/20 0.35
▸ KCNJ6 P48051 1/20 0.34
▸ KCNJ5 P48544 1/20 0.34
▸ KCNJ3 P48549 1/20 0.34
▸ CNR2 P34972 3/20 0.34
▸ CNR1 P21554 2/20 0.34
▸ FPR1 P21462 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24567228 1.00 KDM4C (0.36) KDM4CGAAKDM4EMITFALDH1A1
SCHEMBL24567211 0.86 TMIGD3 (0.39) GAAIRAK4CNR2FPR1
SCHEMBL24567226 0.86 TMIGD3 (0.39) GAAIRAK4CNR2FPR1
SCHEMBL24567218 0.80 TMIGD3 (0.37) KDM4CGAAKCNJ6KCNJ5KCNJ3
SCHEMBL24007634 0.73 KDM4E (0.44) KDM4EMITFALDH1A1HPGDKLF5
SCHEMBL24815180 0.70 KDM4E (0.35) GAAKDM4EMITFALDH1A1HPGD
SCHEMBL24007902 0.70 KDM4E (0.41) GAAKDM4EMITFALDH1A1HPGD
SCHEMBL24567215 0.68 KDM4E (0.35) GAAKDM4EMITFALDH1A1HPGD
SCHEMBL24007637 0.64 ADORA1 (0.46) GAAKDM4EMITFALDH1A1HPGD
SCHEMBL31725450 0.62 PDE1A (0.42) KDM4CPDE1APDE1BPDE1CCNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022140527-A1 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS AJAX THERAPEUTICS, INC. (US) 2022-06-30 — — WO disclosed
Send feedback